Y
Yoshikazu Inoue
Researcher at Cincinnati Children's Hospital Medical Center
Publications - 273
Citations - 17662
Yoshikazu Inoue is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 48, co-authored 233 publications receiving 12648 citations. Previous affiliations of Yoshikazu Inoue include Niigata University.
Papers
More filters
Journal ArticleDOI
2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease.
Yasuhiro Kondoh,Shigeki Makino,Takashi Ogura,Takafumi Suda,Hiromi Tomioka,Hirofumi Amano,Masaki Anraku,Noriyuki Enomoto,Takao Fujii,Tomoyuki Fujisawa,Takahisa Gono,Masayoshi Harigai,Hidenori Ichiyasu,Yoshikazu Inoue,Takeshi Johkoh,Hideto Kameda,Kensuke Kataoka,Yasuhiro Katsumata,Yasushi Kawaguchi,Atsushi Kawakami,Hideya Kitamura,Noboru Kitamura,Tomohiro Koga,Kazuhiro Kurasawa,Yutaro Nakamura,Ran Nakashima,Yasuhiko Nishioka,Osamu Nishiyama,Masaki Okamoto,Fumikazu Sakai,Susumu Sakamoto,Shinji Sato,Toshimasa Shimizu,Noboru Takayanagi,Reoto Takei,Tamiko Takemura,Tohru Takeuchi,Yuko Toyoda,Hidehiro Yamada,Hideaki Yamakawa,Yasuhiko Yamano,Yoshioki Yamasaki,Masataka Kuwana +42 more
TL;DR: In this paper, the Japanese Respiratory Society and the Japan College of Rheumatology collaborated to publish the world's first guide focusing on CTD-ILD, based on the evidence and expert consensus of pulmonologists and rheumatologists, along with radiologists, pathologists, and dermatologists.
Journal ArticleDOI
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society
Takeshi Johkoh,Kyung Soo Lee,Mizuki Nishino,William D. Travis,Jay H. Ryu,Ho Yun Lee,Ho Yun Lee,Christopher J. Ryerson,Tomás Franquet,Alexander A. Bankier,Kevin K. Brown,Jin Mo Goo,Hans-Ulrich Kauczor,David A. Lynch,Andrew G. Nicholson,Luca Richeldi,Cornelia Schaefer-Prokop,Johny Verschakelen,Suhail Raoof,Geoffrey D. Rubin,Charles A. Powell,Yoshikazu Inoue,Hiroto Hatabu +22 more
TL;DR: In this paper, the authors provide diagnostic criteria and management recommendations for DRP that should be of interest to radiologists, clinicians, clinical trialists, and trial sponsors, among others, and provide a simultaneous joint publication in Radiology and CHEST.
Journal ArticleDOI
Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Kazumasa Ohashi,Atsuyasu Sato,Toshinori Takada,Toru Arai,Takahito Nei,Takahito Nei,Yasunori Kasahara,Natsuki Motoi,Masayuki Hojo,Shinya Urano,Haruyuki Ishii,Masanori Yokoba,Ryosuke Eda,Hideaki Nakayama,Yasuyuki Nasuhara,Yoshiko Tsuchihashi,Chinatsu Kaneko,Hiroko Kanazawa,Masahito Ebina,Etsuro Yamaguchi,Jacqueline A. Kirchner,Yoshikazu Inoue,Koh Nakata,Ryushi Tazawa +23 more
TL;DR: GM-CSF inhalation decreased the concentration of total protein and SP-A in BALF, and increase interleukin-17 and cancer antigen-125 in improved lung of autoimmune pulmonary alveolar proteinosis.
Journal ArticleDOI
CYFRA 21-1 as a disease severity marker for autoimmune pulmonary alveolar proteinosis.
Toru Arai,Yoshikazu Inoue,Chikatoshi Sugimoto,Yasushi Inoue,Keiko Nakao,Naoko Takeuchi,Akiko Matsumuro,Masaki Hirose,Koh Nakata,Seiji Hayashi +9 more
TL;DR: Serum markers, including Krebs von den Lungen (KL‐6), surfactant protein (SP)‐D, SP‐A and carcinoembryonic antigen (CEA) are reported to reflect autoimmune pulmonary alveolar proteinosis (APAP) disease severity.
Journal ArticleDOI
Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: The effect of the integrated clinico-radiological assessment
Junya Tominaga,Junya Tominaga,Fumikazu Sakai,Takeshi Johkoh,Satoshi Noma,Masanori Akira,Kiminori Fujimoto,Thomas V. Colby,Takashi Ogura,Yoshikazu Inoue,Hiroyuki Taniguchi,Sakae Homma,Yoshio Taguchi,Yukihiko Sugiyama +13 more
TL;DR: Some cases that had UIP confirmed on SLB for IPF diagnosis were classified into a low-level certainty group by expert chest radiologists and pulmonologists.